Ex parte DECKNER et al. - Page 6




                   Appeal No. 1997-2750                                                                                                                             
                   Application 08/191,734                                                                                                                           



                                                         1                                                                                                          
                   personal care applications.   According to information provided in this brochure, under the                                                      
                   heading “KEY HIGHLIGHTS OF SALCARE SC92,” using this product provides a number                                                                   
                   of benefits associated with liquid dispersed polymer technology, for example, ease of                                                            
                   finished product manufacture; finished product                                                                                                   
                   versatility; cold mixing process; compatible with other cationics and nonionics; low use                                                         
                   level for many applications; and attractive price.  Again, in describing a cosmetic                                                              
                   “cream/gel” base formed with SALCARE SC92, the brochure lists a number of                                                                        
                   advantageous performance characteristics, for example, the “cream/gel” base spreads                                                              
                   easily; possesses “elegant” residual skin feel; conditions and moisturizes; and is non-oily                                                      
                   and non-sticky.                                                                                                                                  
                            We are persuaded that a person having ordinary skill in the art, armed with the                                                         
                   disclosure of the SALCARE SC92 brochure, would have found it obvious to use a suitable                                                           
                   quantity of SALCARE SC92 as the gelling or thickening agent in the topical                                                                       
                   pharmaceutical composition of Kligman.  By thus modifying the composition of Kligman,                                                            
                   per the teachings of the “secondary” reference, a person having ordinary skill in the art                                                        

                            1As made clear in the instant specification, page 16, lines 5 through 11,                                                               
                   Polyquaternium 32, also referred to as SALCARE SC92, is a cationic polymer useful                                                                
                   in applicants' invention.  SALCARE SC92 was commercially available at the time                                                                   
                   applicants' invention was made.  Also see Exhibit 1 attached to the Appeal Brief,                                                                
                   illustrating the formula of Polyquaternium 32 or SALCARE SC92.                                                                                   


                                                                                 6                                                                                  





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007